We build on fall prevention and root cause analysis by asking compliance committees to take a deeper look at resident falls through targeted audits. We share two practical tools to guide record reviews, surface contributing factors, and strengt...

A troubling statistic sits at the center of today’s conversation: 43% of nursing home falls with major injury and hospitalization went unreported through the MDS. We dig into what that means for resident safety, survey outcomes, quality measure...

Join Allan and Anne as they explore a tough topic that everyone struggles with: grief. Anne shares her personal stories about her journey as a caregiver, and how we can help each other remain strong and feel supported in the midst of sadness.

Welcome to Verity's Caregiving Podcast Series! Join cohosts Anne Blust and Allan Stegemann as they navigate the crucial, compassionate, and complicated world of caregiving. Through sharing personal stories and enlisting guests from different fa...

Numbers can light the way or lead us astray. We break down how to build dashboards in long-term care that leaders can actually trust, from defining a “fall with major injury” to validating every step between an incident report and a board-ready...

We map a systems approach to antipsychotic use in nursing homes, from admission screening to documentation, coding, and survey readiness. Our goal is a practical stewardship model that protects residents, preserves data integrity, and withstand...

We unpack how CMS will monitor antipsychotic use in nursing homes, why the national average is changing, and what datasets will be cross-checked to produce public quality measures. We set the stage for part two, where we dig into practical step...

We trace how OIG’s guidance elevates patient safety and quality from ideals to daily compliance work, and share lessons from Corporate Integrity Agreements that separate paper programs from living systems. Practical tools, clear dashboards, and...

We unpack the OIG’s nursing facility guidance on compliance education and show how to move from generic modules to risk‑based, competency‑driven training that protects residents. We connect risk assessments, CMS alignment, and real‑world method...

We examine how the federal shutdown disrupts nursing home oversight, why CMS triaged surveys to emergencies, and the risks created by fewer inspectors and furloughed staff. We share steps facilities can take to protect residents, drawing lesson...

We examine how CMS F841 and new OIG oversight raise expectations for nursing home medical directors, demanding visible engagement, better policies, and data-informed leadership. We share field lessons on antipsychotics, facility assessment, and...

Accurate MDS completion has become a regulatory lightning rod as the OIG and CMS intensify their scrutiny of long-term care documentation. This shift isn't merely procedural—it signals a comprehensive effort to identify potential fraud and ensu...

OIG 2023-2024 Compliance Guidance for Long Term Care Facilities is summarized to highlight importance of a compliance committee and the responsibility to assist the chief compliance officer to develop a robust facility risk assessment. From tha...

In this episode, I will discuss the OIG November 2023 Compliance Officer Roles and Responsibilities guidance. The compliance officer has a responsibility to develop policies and procedures, conduct risk assessments, provide education and traini...

In this podcast episode, the host discusses the 2023 and 2024 updates to OIG's compliance program guidance (CPGs). These updates include a move to publishing the CPGs on the OIG website and the addition of a section on quality and patient safet...

 Skilled nursing facilities are facing changes in CMS survey guidance regarding unnecessary use of psychotropic medications. CMS is closely monitoring the use of these medications, which can be considered chemical restraints, and is asking...

SummaryThe CMS has released updated guidance on the long-term care survey process, focusing on accuracy of the MDS, medical director responsibilities, psychotropic medications and chemical restraints. In addition, the CMS issued clarific...